Rapport Therapeutics (RAPP) Cash & Current Investments (2023 - 2026)
Rapport Therapeutics (RAPP) posted Cash & Current Investments of $436.08 million for Q2 2026, up 67.5% from $260.4 million a year earlier but down 8.5% from the prior quarter.
Powered by 
Analysis
Rapport Therapeutics (RAPP) Cash & Current Investments (2023 - 2026) Analysis & Trends
At the end of FY2025, Rapport Therapeutics' Cash & Current Investments came in at $490.5 million, up 60.7% from FY2024.
- In prior years, Rapport Therapeutics' Cash & Current Investments was $305.3 million in FY2024 (+107.0%) and $147.48 million in FY2023.
- Quarterly Cash & Current Investments has run from a low of $74.27 million in Q1 2024 to a high of $513 million in Q3 2025 over five years.
- On a year-over-year basis, Cash & Current Investments has increased in each of the last four quarters, with growth averaging 90.6% over the last eight quarters.
- The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q2 2024, with growth of 322.6%; the weakest was Q2 2025, with a decline of 22.5%.
- According to Business Quant data, Cash & Current Investments for the three prior quarters was $476.8 million (Q1 2026), $490.5 million (Q4 2025) and $513 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Rapport Therapeutics | 1.24 Bn | 424.19 Mn | - | 436.08 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 436.08 Mn |
| Mar 31, 2026 | 476.80 Mn |
| Dec 31, 2025 | 490.50 Mn |
| Sep 30, 2025 | 513.00 Mn |
| Jun 30, 2025 | 260.40 Mn |
| Mar 31, 2025 | 285.40 Mn |
| Dec 31, 2024 | 305.30 Mn |
| Sep 30, 2024 | 320.70 Mn |
| Jun 30, 2024 | 336.10 Mn |
| Mar 31, 2024 | 74.27 Mn |
| Dec 31, 2023 | 147.48 Mn |
| Sep 30, 2023 | 159.41 Mn |
| Jun 30, 2023 | 79.53 Mn |
API Access
Rapport Therapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=RAPP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "RAPP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=RAPP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();